Poo transplant or "Faecal microbiota transplantation" (FMT) can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows.
Jan 15, 2019
0
65
Inflammatory bowel diseases are chronic, painful disorders of the intestine that afflict roughly 1.5 million people in the United States. Yet the underlying mechanisms of these diseases, which include ulcerative colitis and ...
Jul 26, 2019
0
30
In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.
Oct 10, 2023
0
58
More than 6.8 million people worldwide are estimated to be living with inflammatory bowel disease (IBD). IBD is believed to be the result of a malfunctioning immune system, which results in an inappropriate immune response ...
Apr 7, 2021
1
8
Children with inflammatory bowel disease (IBD) run a greater risk of psychiatric disorders, according to a new study from Karolinska Institutet in Sweden published in JAMA Pediatrics. The researchers claim that more psychological ...
Aug 19, 2019
0
116
An article published in the journal Microorganisms shows that melatonin, despite its antioxidant effects and role in regulating sleep cycles, can worsen inflammation of the intestine and impair the action of gut microbiota. ...
May 9, 2023
1
30
The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn's disease has identified a genetic marker which could individualise drug treatment.
Oct 7, 2019
0
663
(HealthDay)—Low body mass index (BMI) among men entering adult life is associated with an increased incidence of Crohn disease (CD) and ulcerative colitis (UC) up to 40 years later, according to a study published online ...
May 7, 2019
0
7
An enzyme that usually stops bacterial growth in the large intestine stimulates inflammation in some people, resulting in ulcerative colitis—a chronic digestive disease that affects more than 750,000 Americans, according ...
Aug 18, 2020
0
65
(Medical Xpress)—A new study in mice has shown that genetically engineered bacteria can protect against inflammatory bowel disease (IBD), which includes a host of conditions including ulcerative colitis and Crohn's disease.
